An Update on Kidney Stones: Types, Mechanism and Treatment Approaches
-
Published:2023-03-17
Issue:
Volume:
Page:53-62
-
ISSN:0975-4385
-
Container-title:Research Journal of Pharmacognosy and Phytochemistry
-
language:en
-
Short-container-title:RJPP
Author:
Sharma Sonam1, Sharma Nisha2, Chandra Gupta Prakash2, Verma Ruchi1, Yadav Vandana1
Affiliation:
1. Research Scholar, School of Pharmaceutical Sciences, Chhatrapati Sahu Ji Maharaj University, Kanpur, Uttar Pradesh, India. 2. Associate Professor, School of Pharmaceutical Sciences, Chhatrapati Sahu Ji Maharaj University, Kanpur, Uttar Pradesh, India.
Abstract
Kidney stone illness is becoming more common and new studies shows that stones can be linked to a number of significant complications. Renal stone disorder is a condition of crystal concretion that forms in the kidney. It is a growing urological health problem that affects approximately 12% of the global population. Stone generation is a sophisticated process that includes a number of physicochemical phenomena, such as supersaturation of urine, nucleation, growth of crystal, crystal aggregation and retention of urinary stone. An imbalance between substances that induce or inhibit urine crystallisation controls these stages. These facts show stone therapy and stone prevention. There is many misunderstanding regarding how to handle stones among both the general public and clinicians. As a result, review is to consolidate up-to-date knowledge on kidney stone origin, pathophysiology, and management strategies of each kind of kidney stone. The phytochemicals present in the extract contribute to the plant's antiurolithiatic abilities. Several kinds of phytochemicals such as Flavonoids, Polysaccharide, Saponin etc have a favourable effect in the antiurolithiatic impact against kidney crystals, or in terms of dissolving or inhibitory capabilities. However, there is a limited knowledge on nutritional and medicinal treatments for lithiasis and prevention.
Publisher
A and V Publications
Reference91 articles.
1. C. O’Callaghan, P. V. Yangkul and L. Ammi Visnaga, Eds., Blackwell Publishing Ltd., Oxford, UK,doi.org/10.1155/2018/3068365 2006 2. K. Mikawlrawng, S. Kumar, and R. Vandana, “Current scenario of urolithiasis and the use of medicinal plants as antiurolithiatic agents in Manipur (North East India): a re-view,” International Journal of Herbal Medicine, vol. 2, no. 1, pp. 1–12, 2014. 3. V. K. Sigurjonsdottir, H. L. Runolfsdottir, O. S. Indridason et al., “Impact of nephrolithiasis on kidney function,” BMC Nephrology, vol. 16, no. 1, p. 149, 2015. 4. Z. M. El-Zoghby, J. C. Lieske, R. N. Foley et al., “Urolithiasis and the risk of ESRD,” Clinical Journal of the American Society of Nephrology, vol. 7, no. 9, pp. 1409–1415, 2012. 5. A. D. Rule, V. L. Roger, L. J. Melton et al., “Kidney stones associate with increased risk for myocardial infarction,” Journal of the American Society of Nephrology, vol. 21, no. 10, pp. 1641–1644, 2010.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|